Asthma, Blog and Manufacturing - Primary Care Digest

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Asthma

Blog

Manufacturing

Maine and Nevada Update Drug Price Transparency Laws

FDA Law

JULY 22, 2021

Schlanger — Maine and Nevada previously enacted laws requiring drug manufacturers to report information about the pricing of their products. Both states’ new requirements will become effective in October 2021 and should be considered as manufacturers prepare for state drug price transparency reporting in 2022.

Manufacturing

Manufacturing Asthma Diabetes Family

Ninth Circuit Upholds FDA’s Authority to Regulate Stem Cell Clinic Treatments

FDA Law

OCTOBER 14, 2024

(Note we do not discuss the cell expansion variety of this treatment further in this blog as the court quickly dispensed of it as obviously not subject to the SSP exception.) These procedures are offered to treat a variety of conditions, including Alzheimer’s, arthritis, asthma, cancer, etc.,

Clinic

Clinic Patient-Centered Asthma Patients

Maine and Nevada Update Drug Price Transparency Laws

Ninth Circuit Upholds FDA’s Authority to Regulate Stem Cell Clinic Treatments

Stay Connected